PBYI Cost of Revenue

Puma Biotechnology Inc · Cost of Revenue

PBYI logo

PBYI Cost of Revenue

Latest reported$58.20M
PBYI TTM Cost of Revenue ($0.00 → $58.20M)
High-resolution chart · PNG

PBYI cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Puma Biotechnology Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
58,199,000
58,025,000
58,157,000
48,951,000
65,875,000
64,232,000
64,404,000
74,806,000
58,993,000
60,192,000
62,682,000
55,195,000
54,406,000
57,467,000
55,093,000
50,152,000
47,936,000
44,987,000
63,700,000
62,745,000
62,409,000
59,855,000
39,374,000
38,576,000
38,033,000
37,935,000
36,859,000
37,017,000
36,617,000
36,131,000
34,514,000
28,314,000
20,840,000
12,009,000
5,626,000
1,526,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.